Alzheimer's Disease Clinical Trials in Aventura, Florida

4 studies are recruiting for alzheimer's disease in Aventura, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.

    Stage
    Phase 3
    Ages
    55 to 90
    Site
    Local Institution - 2648, Aventura, Florida
    Locations
    144 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT07011745 on ClinicalTrials.gov

  2. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

    Stage
    Phase 3
    Ages
    60 to 85
    Site
    VIN-Julie Schwartzbard, Aventura, Florida
    Locations
    119 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT06976216 on ClinicalTrials.gov

  3. A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

    This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD followed by an Extension. The double-blind part is 72 weeks long, followed by an extension.

    Stage
    Phase 2
    Ages
    50 to 85
    Site
    Visionary Investigators Network, Aventura, Florida
    Locations
    74 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT07094516 on ClinicalTrials.gov

  4. Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

    Bio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine the primary objective. Digital biomarkers and blood-based biomarkers will be tested to determine whether a meaningful rel…

    Stage
    Not phased
    Ages
    60 to 90
    Site
    Visionary Investigators Network, Aventura, Florida
    Locations
    26 in total
    Run by
    GAP Innovations, PBC

    See if you can join NCT06584357 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.